https://www.globenewswire.com/Tracker?data=teOUhkLfr5GMACKuI0ValCzVce_l2ow6jXopEtnadRxE-FTA2hSEjlqpOzg9byccZlBWccl39WaWD32FatnQpA== IR@Pfizer.com

BioNTech:

Media Relations

Jasmina Alatovic

+49 (0)6131 9084 1513

https://www.globenewswire.com/Tracker?data=Obw_ES0IVszq4Ha8bsqEJc0X9HZxh1_n8jlfk7K5_p5e9IRdl6IiMdy2VP0I7QbDPaFkYP_Dn3iWAhLqUdC99DWduWjg5VoxixyqbCFuozM= Media@biontech.de

Investor Relations

Sylke Maas, Ph.D.

+49 (0)6131 9084 1074

https://www.globenewswire.com/Tracker?data=XOmiMTtTsyr62bjicb3AQVu7GNR_srWXDyxhyAgZRxhB_RYw38F16GOkL7ns7zTiL9RKyp1TDScd87IWq8Eqd7GAXHrB5N6iy49GBwq-jDg= Investors@biontech.de

(END) Dow Jones Newswires

October 21, 2021 06:45 ET (10:45 GMT)